Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe a bad next earnings call . . . but most here(retail investors), are in so deep with stock losses . . . they just might s well hang on.
So you are wanting to talk on message board, angry at losses you have in DRIO, or just a wonderful person that is going to save all those strangers you surmise are DRIO investors?
What is your take on DRIO technology?
Will your country accept DRIO mobile reader device for safe use, by its citizens and guests?
If my replies make you simile . . . then give us your rationale for holding DRIO from high buy in range, to present low stock price.
I often make mistakes in investing . . . let the board hear your strategy for failing to back out of your DRIO buy-in position.
You are seemingly a very smart investor . . . what went wrong for you . . . did you have inability to control your psychological
investment component? <---meaning you somehow had error in gauging where to set-up stop loss orders?
Are you thinking DRIO will go private?
or, are you wondering if DRIO could soon sell off its mobile blood
reader to another blood device company, and then continue on with its R&D into devices for 'other bodily fluids'?
You sound EU centric, geographically.
I am North American.
Would a Reverse Split be enacted by DRIO . . . or do we drop to below .10 in March-April?
Anyone?
Lets discuss if DRIO is going to have revenues of $100K or above, for coming earnings. They should list some kind of sales revenue amount. Wondering if they will have short and sweet (regulation only standard) report, or go into some depth for us retails.
Thanks for replying.
I am not mad at anyone, just trying to understand the company potential.
Today, when I went to a certain Monday post herein . . I firstly received an ad touting Vario (not DRIO) blood reader ( how that is possible, and DRIO does not give me an ad on site download . . . well who is to know?).
Alright . . . if you are so skilled as an investor . . . why did you lose $30K on DRIO? Logic should have told you to 'stop' limit order out of the stock IF it fell below your account hurt level?
I hold a small manageable loss in DRIO right now, but $30K is mucho to lose.
How do you know about mother country lawsuit against DRIO executive? What is your source . . . in country newspaper?
Now to the commenting on Paris Conference effect.
Not any evidence in DRIO stock price, today thus far.
WHY?
1. DRIO would have sent team to Paris of say 4-8 persons.
Some should have 'played' the Paris scene for contacts outside the Conference itself . . . just to get double bang for travel bucks.
2. Realistically, a Paris Conference PR should have basically been written BEFORE the Conference was attended. And, the best way to do this is to write 3 PRs beforhand, covering (A) a standard PR announcement, (2) a special update with a little 'frosting' in it and (C) a huge victory for the company PR. A phone call from the conference or secure fax transfer from Paris staff, would give the additional fill-in fluff to add to one of A,B,C pre drawn PR options.
The clock is moving very soon to third month of 2015 . . . some of us are wondering how many more months DRIO funding will last, without new inputs. DRIO . . . your loyal retail investors are bumping around in the dark . . . do you owe us a PR or two in March-April?
Anyone have any clues (estimates) of DRIO 'burn-rate'/ month . . .
I surmise it has to be $400K-$800K IF production in-country is operating and my estimate figure would include rent, materials, wages, and legal fees + advertising; and some level of R&D towards goal of reader of 'other bodily fluids' progress.
Drio2014 . . . perhaps you have something to add to the board about my above? Or, others.
I am not against the company.
I hold long, or short-term as stock price dictates.
Doubt I am exceptional therein.
One day (USA) time left for Paris Conference booth results.
Stock price/'volume does not show (currently), any effect from Paris conference.
Unless DRIO is savings its Paris Conference news effect for coming earnings call, there have been no starling effects?
Its troubling (at least to me), that DRIO has made no effort (nor brought its retail investors up to date) on things like 'donating' some DRIO meters to military (at least USA State National Guard Medical Teams); to try out. DRIO should be cheaper to use on medical testing on new recruits, destine for induction and basic training? Also, emergency response teams probably would like to try some, for instances when highway or home call emergency accidents happen?
Summary reports of their use by such organizations (and a letter from the immediate commander), would be positive for FDA Approval input.
I (and probably others), also want to hear about DRIO meter R&D progress, towards 'other bodily fluids' mobile readers.
It should at least be possible to develop a mobile reader that has magnification SW, for look for Ebola strains, after UV/IR or suitable chemical marker introduction to medical specimen.
I am starting to sense that DRIO is going the APPLE route of marketing to wealthy customers first (nothing wrong with that---follow the billfold money philosophy). However; a high percentage of potential DRIO reader device users would most likely be in health care plans, assigned to lower-income.
DRIO should be giving at least 2-4 mobile reader devices to representatives of sovereign national health care systems, that should be attended the Paris Conference. Has DRIO planned to use
their Paris Conference attendance presence efficiently, by also calling with sales kits (including demo devices), to those Paris-based foreign embassy staffs that did not attend?
Lets see how the DRIO team handles itself.
Their results will show forth next week, in the stock price?
Right now FWDG is telling its investors (new and old), that THEY have the stuff to make miracles in the MJ/HEMP business happen.
Yet . . . we find that 'payday loans' (<-- meant figuratively), wouldn't loan us zip on our debt consolidation plans?
140,000% increase in revenues . . . would not your accounting professor fall out of his chair laughing?
We shall see within two quarters . . . if we have here a paper pyramid scheme worth .0001 or a valid wonderkin company. All the other MJ/HEMP companies are yelling they also have a plan to walk to the moon, so to speak.
Operation Rolling Thunder Debt?
We will bomb the S--t out of the meadows and Jungles, with electronic (I made this!)Picks and Shovels!
Green Power . . . To The Moon, Alice!
What Future World has described as 'hard GOALS' planning . . . seemingly might take more than $3-4 million to bring forth? And who is going to pass the bucks hat for FW . . . even the Greeks realize now . . . high times on borrowed bucks . . . is high times
. . . until the substance materializes out of the smoke and mirrors of magic dreaming?
And, yes . . . I do own long some WF shares . . . just to tempt the time continuum of fate. But only a tiny amount . . . until I see the paper house become bricks of structure.
Thanks for clarifying that issue.
Its amazing that EKSO (the front-runner in tech and government robotic-force focus) . . . has a low stock price (for now) and its competitor has one over $10.
I think this is partly thus, due to labor-intensive assembly for EKSO compared to its competitor.
We are just sitting and waiting for news and earnings effect?
I see EKSO as way better position also for robotic-force human power suits, then IRBT (which is now experiencing fall-off of its retail robots sales and also fall-off of combat robots deployed in ME for IUD use). IRBT recon robot and pack load carrier is our dawning competitor. <---they also may be developing a ground version of medi-vac emergency transportation robot, to assist medics in moving to safer rear care areas . . . while providing suite of med-tech to stabilize patient, in protective cocoon.
ELSO could basically do the same thing, with a protective 'trailer' that can be towed or self-propelled by EKSO suit hook-up?
We could even foresee A/C and heating suit-trailers, with both dual-cable/wireless controls.
BA and LMT and GE should be very alert to future potential of EKSO robotic-assist suits for new profits markets. I should not have much doubt, ten of thousands of EKSO tech suits will be purchased . . . after further cost-effective improvements. In time, EKSO should be able to drop its uit-prices down to $25-50K price range, with 3-D printing and automatic procution lines.
I have thought the opposite may happen, though daily volume has not fallen below average 100DAV. I an just saying, BR is in the game to win at the game. Seeking Alpha wants to get in one's E-mail folder and 'sell' its contents? How else can they make money, more than one way (leading the discussion to THEIR aims, which is whoever pays them to accept artls.)? Nothing new therein, of course. SA.com has really nice comments on their artls., and that is worth the sign-up alone.
My 'take' is yes a BR short sneeze could happen, and then what?
Oil Man thinks BR will be very positive for GLUU investors, just remember to be able-ready to take your short-term short-sneeze profit quickly off the table, so to speak. I suspect most retail investors eventually have turned, to having two stock positions . . . one short-term and one long term.
GLUU is (right now) a leader in VG-ing methodology, and surely worth a long-term stock position effort. There IS a quite good chance of a buy-out and a huge new partner. Is BR that partner possibility? And, has BR size-of-investment set the stage, to prevent any other 'partner' from coming . . . unless they have lots of $$s to offer? Is that actually what BR wants, to happen?
Does GLUU now have a huge guard dog . . . or a tiger cage door left open?
I am saying, BR has huge power to play 'their' profit game-plan both directions . . . do not just accept them as such a nice organization that is nothing more then a mechanism of positivism for retail investors?
I also find a good guess in Oil Man's posting that GLUU will have some steady PR News Effect working for retail investors, as the next few moths pass.
BorisB thanks for expressing your thoughts, as it always helps to have difference of views on DRIO and its tech and their customers/users opinions and thoughts. This is just the kind of dialogue any company or enterprise should be on the outlook for. As one grows older, they slow and start to lose skills and positive perceptions of life. This is just natural . . . aging can be thought of as a disease AND an adventure.
Like a friend of mine that can just still drive safety (has Type 2 Diabetes fro several decades), has an advanced medical degree, and 70+ told me . . . you have to start watching things like going round barefooted (danger of foot wound and bad news for infection). He really is up on his self-care and doing great psychologically. But with all his experience in his field of working with customers, he is 'jaded' on new diabetic tech like portable oral breather insulin pump.
I take a middle-of-road position on customer/user acceptance of new ideas and techs (though I may be all for them), as a retail investor. Note Today's Tesla EV news about results of opening sales in China. Jim Cramer, on his TV finance Show . . . said Tesla great car, but Elon Musk bad businessman. Oh . . . really . . . solid advice from person who has never displayed huge tech skills or degreed experience. But Cramer will have effect on investor sentiment toward Tesla.
My friend has told me of several elderly diseased persons, who DENIED their own medical car case advice and refused to properly take care of themselves, resulting in their further disability and death. <---this psycho-denial is very much a part of disease personal care, especially for those who are weak and suffering a loss of self-freedom. And, not all diabetics have family now, nor caring friends still alive? All I am saying is this is some part of the Diabetes Equation, and potential issues in customer/user-ship.
And, DRIO does have the potential to take diabetic care to another level. Lets see how this company manages its product/service introduction, advertising, orders, revenues, FDA Approval progress, and needed new funding sources.
The great (Goggle, Apple, Amazon, and MSFT) are about as helpful envisioning and helping to fund, new health mobile appls as a four-sided tire on a race car? And, then there is Black Rock with its new emphasis on socially-conscious new fund to start doing nice things for little companies (and glaringly apparent
weak links in social services and health care provision).
What I see here as a problem(s) for DRIO is:
Lack of cash.
Management 'problems'.
Confusion on part of customer/user on which dawning mobile diabetic reader tech to want. Taking a correct and easy blood glucose reading is somewhat more important than deciding whether Atari, C64, or Texas Instruments T80 would be the customer choice for fun and games platform buy-in?).
Company is WAY too 'cards-to-the-chest' formal, on What and Why DRIO has not yet received FDA Approval.
Me thinks, present diabetic portable devices are fine with many diabetes (as to tech), and maybe they just do not want to go online with their health care info? Not everyone wants the cloud. Think like . . . did you really want to relearn another MSFT software? Specially, DRIO may have miss-guessed the techno-alienation of many older diabetics.
OT: That was a cool airplane-car.
In USA Mueller has designed one that operates more like sit-in quad-copter <---with multiple nacelled moving turbo-engines.
Cheaper and faster and easier to land. He has not got it into production in over 10 years. Do you really want an aircraft-car flown by the Crowd Apes, tossing out their empties before the
air-police force them to land?
Your research is excellent.
Now we see the handwriting on the wall.
IHealth Lab Inc. has FDA Approval, lower cost, and they are selling to public (even on Wall Green's website).
DRIO is facing mucho competition.
I guess we can expect little results from booth at coming Paris Conference.
I have always had a strange feeling about DRIO . . . but I took a small chance with its stock. When you have to Reverse Split after dropping over 90% from IPO price . . . that's a fairly clear tip-off company is floundering in the quicksand?
DRIO reminds me of MCZ (mobile/platform small gaming device company) . . . doesn't want to admit its walking dead.
DRIO is looking like its been passed by.
So much mobile health tech coming out now, the 'game' is to see who and what makes it to profitably. I can see that user/
consumers would be very confused which device they might want to settle into using.
Poster on board, roughly stated 'game over' for DRIO, as new funding needs coming due VERY SOON.
Looking like next earnings call . . . after Feb Paris Conference . . . will be crunch-time for DRIO?
Far-out stuff!
Looks like 1984 and Brazil Movies, wherein major private corporations begin to replace government bureaus with their own methods and ideals. Problem is Human Nature does not magically transpose, under a new label. Sky Net meets The Matrix?
Black Rock is so appropriate a name for this investment funding company. Makes one think . . . what do they see in GLUU vehicle . . . for what?
Puzzling that the new Bond game got moved to later in the year.
Maybe . . . GLUU is putting more hope on new Terminator VG content. Arnold-The-T is probably much more sales potential than James Bond?
Thanks for bringing in your special insights to GLUU VGs.
We the board always appreciate your knowledge and imputs.
If you might, what is your take on Robocop as to its 'hits' with online players? Think Robocop will be steady earner for GLUU, to some extend? Or, was it a kind of flop?
Terminator VG could be real big for GLUU: sure hope Arnold has followed its VG construction (he is media sharp and experienced
and knows this is to be BIG Movie rematch for him as returning active actor).
I would have liked it if he did make a provision in the T-VG . . . so that players could design and create their own personalized T-Model AI android . . . from a set of in-common parts and personalize also its game name. What an opportunity for GLUU to expand its game engine and go into another direction of play.
Looks rather like a cat fight is shaping up.
Our only real hope is FDA Approval comes through, and DRIO can get enough orders worldwide to gain that roughly #% of world mobile reader device market.
Just guessing . . . looking like most of competitors are 1-3 years from real product retail/internet site selling competition.
All it will take is bigger $$s partner, to 'push' one of these
competing techs to mainstream medical care.
Which brings up the question: will folks like FDA and Goggle and Apple just open up the competitor free-for-all . . . and then just sit back and let the winner take the market? <---this meaning we DRIO investors may be holding a bad-odds to success ticket, in this Lottery? The small company rarely makes it, or thus it seems.
Drio gets no new funding source in next 6-12 months, we are scr--ed.
The coming French International Diabetic Conference end of this month, will be interesting. Wondering which other mobile reader device competitors, will be present?
Looks like its 'show-time' for a miracle SeaHawks Play Call, in the End Zone.
My take on above is . . . there should be some repres' from major present Diabetic blood glucose readers and medical device companies . . . showing up at the French conference. This cellphone mobile device reader tech, is a game changer and product killer for them. when you go to your local pharmacy store, you see on their shelves the present blood finger prick readers. DRIO us trying to upscale do what they once did for diabetic medical care.
We can only dream the governments attending the conference have national funding, to drop DRIO some more orders and Sovereign Use Approvals. <---Drio . . . did you send them a Product-ED package with an invite to your booth? Drio do you have free samples for them to take back to their countries, and a demo team ready to fly to them?
It sure is puzzling to look at the DRIO financials and see very little R &D funded currently (does that mean their 'other bodily fluids' reader device tech is A-Ok ready status? The Cheques Company figured it out with a different reader insertion doggle at each end of their device. Did DRIO?
This is your low-cost chance DRIO, to let these Sovereign Health Care Providers attendees . . . to GET what DRIO can provide them: more efficient--lower costing--health care provision via their in-country mobile phone systems. DRIO did you do your research of which carrier(s) are set-up in each country, and what phone manufacturer has majority of their phone business?
Lastly, DRIO did you think to invite the Russians . . . they have now huge need for this efficient costing mobile health care device in their vast spread-out geographic country. Contact Russian embassy staff in Paris . . .forget the sanctions garbage . . . tell them you would love to have them attend as your guest.
Black Rock investment in GLUU means basically little, unless other big folks like GS and Vanguard follow them and buy into GLUU. Lets see if it happens. We have no figures to prove that small retain investors are buying into GLUU, just because Black Rock did.
Watch the daily volume and see if its equally buys and sells.
The stock price move up (so far this Monday), shows no evidence of big retail investor buy-ins. Who is BR going to sell to itself? The truth of the pudding, so to speak, will be if GLUU daily volume holds above 3-5Mil shares and stock price keeps slowly rising.
Anyone with Level 2, can see who is wanting in to GLUU.
And, what is on-balance volume ratio of shorts/longs telling us?
GLUU might top-out this week, after conference @5.30-5.50 range?
And, then turn south? We do not know yet . . . lets see how stock price goes. GLUU could soon drop to 4.15-4.50 area, and wait for next earnings call boost effect?
I am suggesting more $$s can be made on GLUU by having it keep cycling up and down, in a price range. What will Bad Rock do?
Night Trader . . . any word on Terminator VG format . . . will it be more movie clip type of action . . . or just another Deer Hunter shoot-and kill Gallery? Would something like Arnold-The-T call on VG players to join him and chose weapons upgrades? Will we have an upgraded story-line included? I guess I am asking, would Terminator VG be more KKH: type of VG?
Is Terminator going to be released in July-August time frame?
Just me . . . I do not see it possible for 2015 (unless new singer game, and terminator movie game are huge successes).
When KKH: VG of GLUU was successful as a new genre of VG mobile . . . this same pump fever was present.
If GLUU had other VG successes for 2015 . . . like its street racing one)for instance, to add to profitable bottom line and we had a buy-out offer . . . than $13 is in target stock range.
Anything over $9-10 in 2015 (late fall time period), would be the magic.
If GLUU 'falls back' in stock price relatively soon (roughly within a month's time), I would say take-a-chance and buy in for $1-3.50 price uptick.
I am no future scenario channel-er . . . just my wild guessimates.
I am sure other posters have counter-arguments for super-moon countdown stock flight Hope I am wrong, and they are the right stuff.
True . . . I was just trying to get around the notion of how and when GLUU will be selling down. Daily volume is reducing and topping behavior is most notably (I am saying GLUU will not be experiencing any renewed near vertical stock price news effects).
Why would not a large Level 3 info Trader (Black Rock), not foresee the opportunity to now make more money on GLUU by shorting it, while holding some of their shares bot at much lower price range?
It would be about 6 months for GLUU to obtain $7+ stock price effect, from new games due? In the mean time Black Rock can party, with moving the GLUU stock price lower?
Lets see what Mother Fate (Black Rock)Loves Yah . . . to paraphrase what Detective TV Show KoJack used to say.
All I am saying is, when the little crowd quits buying . . . shorting coming?
Hope you are right . . . and I am wrong about GLUU stock price going down next week.
I certainly hope for all our sakes, you are right about very soon FDA Approval.
Thanks.
Very impressive . . . though in comments to the video, someone stated maybe not this year released.
Vestigen apparently using IR scans as search tech in their Tri-Corder. A really neat concept was Vestigen was able to develop both types of sampling on the same mobile device (one slot at each end of device). I suspose Vestigen is to manufacture in Singapore? Anyone with any brain cells is moving out of China, now.
Big competition for DRIO, though no reference to cost of device and test strips. They had bad E-Website design (to me). I do not understand Goggle . . . they cost a conference for innovation and then seemingly do not write checks to the companies that show up with prototypes.
Now, we DRIO stock investors see another part of the puzzle . . . Goggle lets the little innovators fight each other to get appls developed, and Goggle sets back and lets the winners have access to its Appls. store. This philosophy thus lower the chances for DRIO to get new funding/partner sources. <---who wants to fund goggle appls store, with their own company funds?
The country (and large multinationals), with the most scientists and engineers and production 24/7 facilities wins the market.
And guess who has the most $$s for political donations?
The USA is off fighting absurd deficit funded Sand Wars . . . while its competitors slowly crush its domestic and foreign markets.
Black Rock might be waiting for next Monday VG Conference in Calif., and then will decide whether to sell some GLUU shares and then short some?
Friday chart (to this time) is showing no upward price direction, and little shorters will not hold their positions over the weekend?
Great find.
TellSpec (the Canada Co.)is the type of stuff that DRIO needs to contact Texas Instruments for (the IR scanner tech). TI has already done the R&D, and DRIO can license the TI tech and proceed with a portable scanner device for numerous industrial and military customers. Seems like I saw the use of a surface IR scanner, to obtain diabetic measurement from blood flow in wrist area. One would strap on something like a wristwatch, and get a reading from your wrist veins.
As I have stated, DRIO does not have much time (1-2 years), before competitors are on the market competing with it.
I suspect DRIO (right now) is cash poor shape, and may not get FDA Approval by July 2015 (clock is ticking, and FEB month goes fast).
No new evidence of DRIO insiders acquiring new stock.
Price/Volume of stock shows no faith in DRIO, right now.
Most are setting on their shares, and hoping for good PR news catalyst effect. Could get +.10-.30 uptick, if soon earnings show over $100K in sales revenues. Or, conversely, DRIO stock falls to near .10 w/o good earnings report?
I conducted some quickie research also.
Looks like the Boston Dynamics relationship is centered around the Talos (Iron Man) DOD contact, and that's about as far as you get info on (vague purposefully). The DOD contracts and funding, is kind of 'off-the-books (of EKSO) potential accounting?
But that said, we cannot but soon began to see its effect on EKSO stock price (Going Up!).
EKSO is also working with 3-D Systems company . . . putting the the two ideas together, we could foresee 3-D printing, as a way to lower EKSO suit cost per unit?
Right now, the EKSO is labor intensive (rather like I-Robot company robots . . . lots of hands-on assembly costing involved).
Was impressed that Goggle is foreseeing the vast potential of 'force suits', in many 'fields'.
Read artl. that EKSO strategy is to use patents worldwide, to generate revenues for itself.
Management experience and marketing skills are rare talents for a company to possess and EKSO appears to have a big plus score in both instances. Pour in innovative
perception and engineering, and the pot gets way tasty.
EKSO is a no-brainer for long-term profits to us retail investors.
I suspect EKSO is not interested in being bot-out.
I agree with others comments to effect: BUY anywhere near this level and hold some LT.
My personal view: right now in this mixed up economy/world . . . one could hardly make a more significant investment opportunity than EKSO (regardless of whether the economy in next few years goes up or down). <---make your own decision and DO NOT invest in EKSO unless you can afford the potential risk or can envision its revolutionary price appreciation tech aspects.
Maybe all we need is some Special Forces Suit contracts, and someone like LMT or BA to help us create a robotic force build around drones and robot tanks to change the revenue landscape?
We need major funding and orders, to get the per suit price down.
Where is Goggle, when you need their novel funding tech approach?
Anyone expecting record earnings Wed Earnings call?
We may see drop in stock price Thursday, Friday?
I am seeing new Arnold Terminator Movie Ads on TV.
This could be very good movie VG connection for us, depending how its done.
Hope GLUU spent some effort to expand the VG into a carry-on of the story, with some extras. It needs to be more than KKH: in format and novelty.
I am thinking lots of Sci-Fi gamers out there, ready and wiling to play such a game.
We need (I expect) some type of Titan Fall action video format to it, that allows player to enter the game as a team member.
We might see $100-200 Mil in revenues from it, if so GLUU stock price should bump up over $5 by August-October, 2015?
I am also hoping Arnold took a cue from KKH: and spent some personal time with GLUU, to develop a richness in the game (and used some of his money to do it).
Arnold was working with Stan Lee to create a kids spy-type VG on the lines of his True Lies Movie, but got Maid-ed.
The new Terminator VG could become the new GLUU form of expanding directly into competition with largest VG companies, and if thus, they will take note.
Think if GLUU went all out and called up Disney/Hasbro and make VGs based on Marvel characters and Toys . . . Phone Home GLUU?
GLUU should look into using an expansion port solid state stick drive, using quad-pro multiple layer parallel processing capability chips, as a way to 'juice' the content of their mobile phone/device games? Think AMD.
Nothing like a little accelerator to put the Metal To The Peddle?
GLUU could then use the cloud, via a special ID chip signal, to sell the VGers on
buying up to new and novel twists to a VG play.
But I doubt they (GLUU) would think along these lines.
This is quickest way to 'juice' VG content and performance vistas, and one can also be able to utilize the GLUU VG commonanlity SW platforms, to create an extra market product that mobile VG players might want to purchase to enhance their GLUU game choice. But why dream of such things.
May the winds of chance save us . . . if the Terminator VG is just another Deer Hunter shooting Gallery experience. KKH: was not . . . so GLUU . . . what are you planning . . . a run for the cliff, straight smash into the wall, or a rocket man liftoff?
That's an interesting viewpoint.
Friday EOD volume and price, tends to confirm no one knows about DRIO (or they do not believe in it).
It is mysterious how a company such an DRIO, is not getting any buying support on its stock.
Rather like your next door neighbor kid built himself or herself a website, after reading a book 'How to Make Your Riches Online!'
Build it . . . they will come.
Lets see if DRIO makes it to July 2015, without new funding needed.
Worse case . . . DRIO . . . sells itself to another Israel Shell and the adventure begins again.
Would it not be something to be able to see who shorted this stock from its IPO, cause I doubt most retail investors could procure a short position via their online broker.
Lets both hope DRIO does some kind of miracle Hail-Merry partnering/funding hookup and all is golden arches. I mean . . . what we are seeing now each day in the stock price . . . is just the calm before the storm.
Well I never rains but it shines!
We finally got some useful news (about Israel HMO partnering with DRIO).
The user health data should provide the tipping point, for USA FDA Approval during 2015?
I really like the way DRIO informs its retail investors of company milestones . . . of course I do.
DRIO is still acting like us retail investors are of no use to them now.
I guess we are not after we were shorted from IPO price, to get the funding to make DRIO mobile diabetic device HAPPEN?
Or, am I way wrong in my viewpoint of who got the benefit of the fall from the IPO price, to present sub .25 stock price value? Oh . . . I know . . . it was just some random retail level super gutsy small investors shorting their initial buy-in IPO price? What models of private enterprise, with Level 3 info, etc. . . . to barrel shoot the fish.
We retail investors are not out of the woods yet.
Early day . . . the stock price PR effect does not show . . . down *.02 on low volume. I guess the fish are gun shy?
Nice work, on scouting the e-commerce sites.
I do not have the time to look over these sites as you and others do.
From a fundamentalist stock analysis viewpoint, one currently lacks the info (perhaps until next 1 or 2 earnings calls), as to where DRIO is at in product development and marketing.
Technical analysis is also vapourous as to what we are seeing in stock price (is it basingat a now higher price range, or at its new resistance price level)?
I am beginning to suspect (as you and others), that DRIO has thrown a hay-el mary
product introduction pass, type of thing. 'Get it out there and lets see how it goes'?
To me, DRIO is being very evasive as to current status of the DRIO mobile reader.
The user comment you high-lighted seems to tell us there are operational problems with the initial design of the device (and maybe even in its manufacturing quality)?
There also is seemingly a lack of acceptance of the product; commercially, user-wise, and professional care provider awareness of?
This leads me to surmise, DRIO is constrained in knowing how to get consumers to want to use the device. If professional care providers are concerned as to the pricing efficiency of the DRIO device test strips (on their medical care clients
budgets), that implies an uphill battle for acceptance? Reality maybe a lot different than the dream, so to speak.
If one goes to the druggist, they will find displayed up to 3 or 4 different brand name devices currently being sold, that are comfortably already established and trusted. I should think large scale medical device manufacturers would be keen, to attempt their own versions of what DRIO is doing. <---And DRIO, has no $$s legs to stand on, to defend itself therein.
Unless starling sales contracts are achieved at the upcoming Feb Paris Diabetes Show, I do not expect more than .02-.10 stock price pop effect thereof. We might also hope for some kind of partnering interest to surface at that coming conference?
That might get us .20-.45 stock price rise.
DRIO still is off-the-radar of consumers and care providers?
The potential of the diabetic mobile communicating online reader may be at an earlier stage of acceptance, then many of us had thought.
DRIO has never made clear what segment of the diabetic income user spectrum, it has targeted. The 1-3% of diabetic device market DRIO has hoped for (to make it profitable company), might just be the high $s income segment? So only certain doctors would be servicing that patient segment.
And, are we just selling predominantly through online ordering?
Also, are we using online buyers as a means of developing a low-ball form of pre-clinical trial datum, to support our FDA Approval?
As I said in some recent posting, my own take is DRIO needs to have a two-point marketing attack to get their product recognized: go to professional care attended
Diabetes Conferences AND start going out to Diabetic user groups and show-and-tell demos of the DRIO mobile reader device.
The very recent diabetic reader device competitor, Dex Com FDA emergent use Approval has not been clarified (as to how it was obtained, example was some form of clinical data testing provided and involved in the FDA Approval Decision). The FDA (kind of) just said, generally to the effect . . . We make no legal decision on the device's (Dex Com) usefulness or medical success at being part of a diabetic care process. <---we just think its new tech that could help in diabetic medical care and want to allow it to be used between the customer/user and the medical health care professional . . . and we want to look over your shoulder and see how it goes.
Personally, unless Dex Com goes into heavy marketing costs . . . I do not foresee more than a few thousand being sold, initially.
Just guessing, I would say DRIO has over 5K of their devices in customer/user hands at this time. Please, if others have better info, please to provide it to the rest of us retail investors walking around with our hands over our eyes. DRIO has not been very fore-coming with device placement figures from within all the countries National Health Care Plans that have approved use of DRIO device reader. This kind of presents a mystery to current and potential retail stock investors, as to what is actually going on herein. If your product is going forward great guns . . . why not toot your own horn a little?
Marketing would be the 'trouble area' for any new product and business venture.
Personally, I have and am taking the bet on DRIO technology. I (and other posters) feel the spotted fox 'will out Watson . . . the game is afoot', within the next few quarters of 2015. If no progress by end of 2015 . . . hmm.
The DRIO product is manufactured in Israel . . . but until just recently DRIO HAD NOT had their government backing. Would not one build their base in-country, as an initial support for going to overseas markets? I guess I funked Marketing 100, oh well.
Be that we present retail investors, believe in DRIO tech potential we sit and await the events of 2015, and are trying to tea leave read the bland DRIO periodic PRs.
New funding scenarios will be more than interesting.
The DRIO Ad budget = online and website, attending professional conferences, and an occasional interview (why do they not go on Dr. Oz type of shows), and it seems they have some retail sales persons that drop into pharma retailers. I should like to see some TV and newspaper ads and calls to senior groups, etc. to attain in store display staffed demos. But DRIO management is so keyed (it seems) to electronic face book type of promotion.
Not much we can say . . . but new funding is surely needed, management was 'green' in ability right off the mark in experience but has filled itself out with more seasoned talent (see press releases in News).
Current stock volume is so low that only daily or short-term trading seems to be happening.
I am underwater about 50% from the recent pre-split stock price.
A number of us are looking now for a buy-out or some partnership funding.
From IPO stock price to current price of DRIO shows a complete lack of favor-ment of retail investors monies return. Nevertheless, I and other hold our shares, as the DRIO tech seems very favorable to future of health care expense and treatment possibilities.
All us retail investors are all in the same lifeboat herein, using flashlights to look
into the fog the company has about itself.
Perhaps there are others that have more detailed insight in to the stock?
Nice of them to buy and support the small company product.
Sure looking like small independent business model (that involves tech devices), is moving towards a future of getting its funding from the large guys. This is really apparent in bio-tech, for example, where a major company hooks up with a smaller one and buys some of its stock, as they cement a joint development venture. <---you get to control access to your future product provider and do not have to explain any 'problems' of association (as you never really bot the whole company). One can then off-load your development failures as a form of off-book-accounting? 'We were there . . . but we didn't do it'. Cheap and efficient at half the price.
DRIO system of mobile 'bodily fluids readings' would appear to be a much better Goggle investment than the counter-shake tech spoon? Please DRIO . . . do invite Goggle X-teams to come and stop by your booth (or seek them out), at the coming Paris Diabetes Conference show in Feb.
Your retail investors would love to see courtship of DRIO and Goggle!
Aged and handicapped are going to be increasing part of every National health Care Plan, AND mobile health device readers are so a part of whats coming.
Goggle . . . apply the anti-shake spoon tech to drinking glasses and make a talk-to-set of eye-glasses that zoom-in-out on command.
As to Apple cash . . . Amazon also has lots of cash and its suffering fall-off in its sales. Fire TV has not done very well to date. I do not see anyone looking at their Apple wristwatch display.
China controls Apple by the Apples.
Sure lots of folks like Apple as an exclusive high-end toy of display, nevertheless there is a cost-barrier to buying such a cell phone.
All I am saying is Apple is NOT the market share percentage leader in mobile,
Google is. DRIO is Goggle system user.
The EU market is not moving to Apple products.
Its growing into Android system market user.
Apple high price products will gradually keep losing market share to Android.
The price of Petro is not going to stay down either and that means we are headed back to inflationary effect on our disposable income purchasing power . . . its going to have new user Carbon Taxes placed on it; regardless of what Brent price it stabilizes at . . . governments need new forms of tax revenues. In such a falling living standards class society, substitute products and services are going to be chosen over the previously owned image product. And Samsung, for example, is pushing hard to equal or exceed Apple quality at a lower price range. Apple's cash holdings are totally dependent on its ability to push the superior quality image, based on pricing point.
I completely agree with your comments on DRIO . . . and they better have a funding/partnership plan or we do fall back down in stock price.
Its a real problem to boost this stock price range we are in now, without user unit sales figures and good evidence of revenues. The recent Israel specific PR still leaves us wondering, why all these nations allowing DRIO mobile device use, are not contributing to DRIO profitable bottom line.
You are exactly right, its appears its going to take several quarters to get DRIO going . . . do we have that time in our favor?
Dexcom is an APPLE specific device . . . DRIO is Android-based.
Ask yourself who has most of regular folks phone market worldwide . . . its Android.
Cost-to-use: DRIO hands down . . . Amazon says $300+ / Dexcom device and it has higher priced test probes. Dexcom uses sub-Q skin probe that can be used up to 7 days safely.
I do not like the idea of having a diabetic patient with an installed sub-Q insert area on the skin. Sounds like infection central station for skin problems.
DRIO also has said it can use its technology, to develop testing for 'other bodily fluids' . . . can Dexcom?
Compare Apple to Android . . . who has most money?
Which company has highest R&D budget?
Many companies are eating APPLE, as each of them chips away at its silly high-pricing points, for its retail and business products.
Total up the competitive companies R&D fundings and staffs, Apple is facing huge competitive forces that will out-innovate it and out-spend it. Each competitor is taking aim at a specific part of Apple's present and future product lines.
Apple is basically a dying company, with high-end narrow customer base . . . Android/DRIO is my bet in the new economy. Also note, that Elon Musk (tesla) has obtained funding from Goggle for a new form of world-wide, satellite-based internet.
Most of world (like us) are getting poorer, not richer.
Even mighty MSFT, is now having to bow to Android market share marketing . . . witness MSFT to give away Windows 10 to its customers.
Dexcom is a private company.
We own a public stock company.
All we are waiting for is DRIO, to approach Goggle and talk shop.
Goggle just has to make a few phone calls and FDA will roll-over.
Goggle is the super-bowl champion in mobile electronics: and they do not need to use deflated balls.
Mobile health readers IS MAJOR way to improve efficiency and cost-structure of Health Care favorably, for everyone involved.
Why not DRIO call-up Goggle and present info that its mobile reader device is ANDROID
phone system based, and a superior product to Apple offering? Maybe Goggle would like to promote an R&D check and tech assistance agreement to DRIO . . . AND send a letter to FDA in support of same approval status for DRIO? Guess who gave big $$s to Administration favored campaigns and is on the approved White House Guest List?
I do like the press release wording you mentioned . . . leaves FDA with political wiggle room, in case they get a call. Stock wise . . . things are looking better for DRIO also FDA Approval before June 2915?
I agree with both of you on buy-out possibilities.
DRIO has done the initial R&D, stared the marketing, and set-up a patent plus achieving National Health Plan approvals.
$30-70 Mill in a buy-out would be suitable figure?
Perhaps one of the current 'blood-stick' device meter manufacturers would be the interested party? Maybe even PFE or Goggle or Amazon?
As an after thought . . . the way DRIO stock was handled from IPO price . . . a buy-
out does seem the direction to be traveled.
This is great stuff.
Lets hope for a stock price bump next month, and a bland PR from DRIO.
Excellent news! Thanks.
It will be exciting to see how many diabetes want to come forward in public and admit to their disease at the booth. After the show is over . . . Brenda . . . why not visit some Jewish schools and senior centers?
My question: why now?
I would have naturally assumed an Israel based company . . . would have done this firstly . . . like about IPO time?
Why cover your country base last?
The strategy herein (by DRIO) seems . . . strange.
Israel has . . . what . . . at least couple of 100,000 diabetics of all types <---Lets just estimate that its a true ballpark estimate figure . . . OK . . . lets further say . . . after demos of the DRIO device . . . 50% (100K) like it and want to use it, for convenience and motivational and national efficiency desires. What kind of yearly profit would that have brought to DRIO? Surely over $100K.
And, we have not even considered the religious duty to care for your own spiritual brothers and sisters needs, in a very close mono-culture association.
Not bad . . . for a start-up company to tout about.
And, being as Israel is an advanced medical care plan country and tech-smart. any clinical testing and user data would have been more than valuable to a start-up, one might ask quite plausibly . . . why did this not happen very early on?
Would not EU and USA and Japan governmental agencies, look with much favor upon such data studies of users from Israel, in making their in-country use commerical decisions approval? I certainly would.
The potential movie plot is starting to unwind herein . . . and are we being told that Israel WAITED for the DRIO mobile reader device to be tested overseas, first?
That would be analogous to proposing Israel would wait and test its ARROW Anti-Missile Defense System overseas, before it protected it own citizens from harms way?
What about all this stuff about potentially being able to read 'other bodily fluids'
medical and user testing data?
Would not such novel reading capabilities . . . kind of bring out the gold . . . by most governments and security and business interests?
Its confusing WHY this is happening (just now?).
Israel government should have been all over this company (GS fronted the IPO) . . . hello!
There has always been this (buy us . . . we are great, 'connected', and know what we are doing!) type of attitude. OK . . . where is the beef . . . all I see is IPO price to less than .25!
What is really holding DRIO back . . . I mean 4-5 world governments are backing this product for use by their health plan customers.
Can the 'problem' be as simple as customers are 'gun-shy' of new reader devices for diabetes? We investors surely hope not.
I would recommend to by pass the professional presentations and go directly to the world Diabetes Associations, and start educating user groups on DRIO mobile reader device product. Use a two sales front approach to marketing.
You can kind of bet the FDA and the doctors are going to be taking notice of DRIO reader tech . . . when their patients bring it in to the office and say 'look at this . . .can we use it together? I got it in Canada, or they were passed out for free at our local meeting and demoed there'.
Next earnings call . . . should we investors not be seeing say $100-400K sales revenues . . . touted in the call briefing . . . as a DRIO accomplishment?
I have said over and over again . . . give some to Vets organization . . . USA National Guard Unit and test some soldiers and their families for diabetic levels.
Diabetes is a hidden killer that slowly moves in on individuals, and they do not realize why . . . they are feeling 'sickly'. Is DRIO just going to stand there in the funding highway and get run down? Lets get creative!
Is this 'a build it . . . they will come' company?
Or, a build it . . . WE show it company?
Folks (users) are not just going to buy this off the internet . . . they want to see and feel it.
BOD's . . . . clock is ticking . . . competition maybe 1-2 years from market.
You got the $$s to fight a patent war, while the court allows contested devices to be sold?
This really great news!
We should now see some definitive revenues in coming months.
This could be very positive for data match-up with USA FDA Approval?
It has always puzzled me why DRIO had little info on its device use in its home country.
Now . . . where will new funding come from for increasing production of DRIO product?
Whats with these folks being able to post their commercial ads in the normal dialogue posts here? we joined YF message board community?
Most penny stock promos are 'positive' . . . they never tell you NOT to buy a stock?
Abe in back in Japan . . . did DRIO contact his power house business group that visited DRIO ME base of operations?
Where is DRIO PR of 'positive talk continues' with FDA?
QUESTION: What kind of net security does DRIO provide to its customer/device users, to protect their data online? Not a word has been said about this vital appl problem . . . does DRIO have a security chip nested in their mobile device reader?